Latest stories on APRE
Aprea Therapeutics, Inc. (APRE) files 8-K
SEC 8-K50 · neutralgeneral
Aprea Therapeutics GAAP EPS of -$0.07 beats by $0.16
Seeking Alpha63 · neutralearnings
Aprea Therapeutics Announces Second Quarter 2026 Financial Results
Business Insider56 · neutralgeneral
Aprea Therapeutics, Inc. (APRE) files 8-K
SEC 8-K34 · bearishgeneral
Aprea Therapeutics, Inc. (APRE) files 8-K
SEC 8-K50 · neutralgeneral